As we reach the middle of the month, we review moves from smid-cap biopharma companies during this past week. See Table 1 for weekly moves and moves YTD for companies and categories on BPIQ.com compared to XBI.
Table 1. BPIQ company weekly moves and YTD moves
Highlights for the week of 2/14 - 2/18
Biggest positive move
$BDSI +52.8% Collegium to Acquire BioDelivery Sciences in an All-Cash Deal
Biggest negative move
$LRMR -64.4% Larimar Therapeutics Provides Update on CTI-1601 Clinical Program (clinical hold remains)
Additional big moves
$HOOK +50.7 HOOKIPA and Gilead Amend Collaboration and License Agreement to Develop Immunotherapies Against HIV
$IBRX +22.3% ImmunityBio Completes Acquisition of Athenex’s Interest in Dunkirk, New York Advanced Biotech Manufacturing Facility
$KPTI +19.83% Buyout rumors
$TGTX +9.5% TG Therapeutics Announces Data Presentations from the ULTIMATE I & II Phase 3 Trials of Ublituximab in Multiple Sclerosis to be Presented at the Americas Committee for Treatment and Research in Multiple Sclerosis Annual Forum.
$MRTX -8.7% U.S. Food and Drug Administration (FDA) Accepts Mirati Therapeutics' New Drug Application for Adagrasib as Treatment of Previously Treated KRASG12C-Mutated Non-Small Cell Lung Cancer
$PSTX -15.2% Poseida Therapeutics to Present Interim Results from Phase 1 Trial of P-PSMA-101 at ASCO Genitourinary Cancers Symposiu
$SAGE -17.5% Sage Therapeutics and Biogen Announce the Phase 3 CORAL Study Met its Primary and Key Secondary Endpoints - Comparing Zuranolone 50 mg Co-initiated with Standard of Care Antidepressant vs. Standard of Care Co-initiated with Placebo in People with MDD
$ATXI -47.5% Avenue Therapeutics Announces Outcome of FDA Advisory Committee Meeting on IV Tramadol
Highlights for next week
$RETA PDUFA for Bardoxolone Methyl
$CLNN CNM-Au8 MS data at ACTRIMS Forum 2/24/22
Quarterly reports from companies with approved product:
$ESPR
$HALO
$PTCT
$BCRX
$CLVS
$GTHX
$TBPH
$TMDX
$AGIO
$COLL
$EBS
$FOLD
$LNTH
$SAGE
$TVTX
$VCEL
$MGNX
$PCRX
$BHVN
Watch over the next few weeks for quarterly company reports including commercial sales
See our Big Movers post to learn about the upcoming Feb Big Movers/Movers to Watch
$BDSI $LRMR $HOOK $$IBRX $KPTI $TGTX $MRTX $PSTX $SAGE $ATXI
Comentarios